Company intelligence / Profile preview

Renhe Yikang

Ownership: Private
Development stage: Other

Overview

Renhe Yikang is a China-based pharmaceutical company involved in both new drug development (small molecules) and generic pharmaceutical manufacturing and testing. They have programs in early clinical development for indications like asthma and have completed bioequivalence studies for generic drugs.

Therapeutic areas: ImmunologyPulmonologyCardiovascular
Modalities: Small moleculeChemical drugs
Industry: Biotech

Partnerships

Possible collaborations with local Chinese CROs/instrument suppliers like Jiahang Instruments

Beyond the preview

Go deeper on Renhe Yikang.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Renhe Yikang.

Explore the full profile